Chembio diagnostics, inc. (CEMI)
CashFlow / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS:
CASH FLOWS FROM OPERATING ACTIVITIES:
Cash received from customers and grants

37,930

29,804

24,971

16,947

30,174

23,898

29,778

23,810

20,335

14,534

Cash paid to suppliers and employees

45,655

41,624

30,028

23,677

28,382

27,724

27,506

23,048

18,055

13,507

Amount of cash outflow from operating lease and finance leases.

640

0

-

-

-

-

-

-

-

-

The amount of interest and tax expenses, net.

-689

38

-

-

-

-

-

-

-

-

Income taxes paid

-

-

0

-

-

-

-

-

-

-

Interest received, net

-

-

22

25

2

5

5

7

6

4

Interest paid

-

-

0

0

0

0

0

9

18

14

Net cash used in operating activities

-9,055

-11,781

-5,034

-6,704

1,792

-

2,277

761

2,268

1,016

Net cash used in operating activities

-

-

-

-

-

-3,820

-

-

-

-

CASH FLOWS FROM INVESTING ACTIVITIES:
Patent application costs

297

0

-

0

550

0

-

-

-

-

Purchase of businesses, net of cash acquired

100

5,491

0

-

-

-

-

-

-

-

Purchase of RVR Diagnostics Sdn Bhd, net of cash acquired

-

-

850

550

0

0

-

-

-

-

Acquisition of and deposits on fixed assets

3,502

1,467

1,026

118

480

1,452

885

872

726

182

Amount of increase (decrease) from adjustments on working capital related to business combination.

-145

0

-

-

-

-

-

-

-

-

Net cash used in investing activities

-

-

-

-

-

-1,452

-

-

-

-

Net cash used in investing activities

-3,753

-6,958

-1,876

-668

-1,030

-

-885

-872

-726

-182

CASH FLOWS FROM FINANCING ACTIVITIES:
Payments on debt issuance costs

186

0

-

-

-

-

-

-

-

-

Proceeds from note payable

-

-

99

0

0

-

-

-

-

-

Payments on note payable

181

64

0

-

-

-

-

-

-

-

Proceeds from option exercises

32

71

34

57

0

237

31

120

287

37

Financing cash flows for finance leases

19

0

-

-

-

-

-

-

-

-

Proceeds from issuance of long-term debt, net

18,850

0

-

-

-

-

-

-

-

250

Expenses from sale of common stock

-

-

-

-

-

-

0

0

-

-

Proceeds from credit line

-

-

-

0

700

0

-

-

-

-

Repayment of credit line

-

-

-

0

700

0

-

-

-

-

Proceeds from sale of common stock, net

0

27,476

0

12,493

0

-

5,408

0

-

-

Payment of license obligation

-

-

-

-

-

-

-

-

875

0

Payment of loan obligation

-

-

-

-

-

-

133

53

54

32

Payment of capital lease obligation

-

-

-

-

-

-

0

14

24

21

Net cash provided by financing activities

-

-

-

-

-

237

-

-

-

-

Net cash provided by financing activities

18,494

27,483

134

12,550

0

-

5,306

52

-667

233

Effect of exchange rate changes on cash

61

-9

-

-

-

-

-

-

-

-

DECREASE IN CASH AND CASH EQUIVALENTS

5,746

8,734

-

-

-

-

-

-

-

-

Effect of exchange rate changes on cash

-

-

13

0

0

-

-

-

-

-

Proceeds from issuance of common stock

0

27,476

0

12,493

0

0

5,408

0

-

-

INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS

-

-

-6,764

5,177

762

-5,035

6,698

-59

874

1,068

RECONCILIATION OF NET LOSS TO NET CASH USED IN OPERATING ACTIVITIES:
NET LOSS

-13,675

-7,865

-6,371

-13,347

-2,397

-1,137

530

941

6,208

2,513

Adjustments:
Depreciation and amortization

1,916

902

1,276

1,139

1,372

739

607

523

437

283

Loss on retirement/sale of fixed asset

-

-

-

-

-

-

-

-

-

-3

Share based compensation

1,655

632

384

304

334

447

331

318

189

170

Change in deferred tax liability

-513

-78

-

5,800

-1,170

-403

458

471

-5,155

0

Fair value adjustment to contingent consideration

-

-

148

0

0

-

-

-

-

-

Provision for doubtful accounts

20

0

-

-

-

28

-34

28

-5

15

Refers to the change in deferred tax assets during the period.

-

-

0

-

-

-

-

-

-

-

Changes in assets and liabilities:
Accounts receivable

-3,764

5,150

-1,298

960

-5,915

3,774

-263

1,850

-952

2,185

Inventories

1,457

3,077

1,088

-242

-60

449

700

187

951

-206

Prepaid expenses and other current assets

-64

118

-285

136

190

-32

159

20

70

-61

Deposits and other assets

90

0

512

-1

0

279

2

-0

6

-93

Accounts payable and accrued liabilities

-441

2,599

182

211

-2,144

636

1,005

514

733

149

Deferred revenue

-297

372

-342

-

-

-

-

-

-

-

Customer deposits and deferred revenue

-

-

-

-

-

-340

23

-23

65

-

Net cash used in operating activities

-

-

-

-

-

-3,820

-

-

-

-

Deferred revenue

-

-

-

39

13

-

-

-

-

-295

Net cash used in operating activities

-9,055

-11,781

-5,034

-6,704

1,792

-

2,277

761

2,268

1,016

Supplemental disclosures for non-cash investing and financing activities:
Value of deposits on manufacturing equipment transferred to fixed assets in noncash transactions during the period.

430

257

174

0

20

603

521

229

0

338

Value of deposits and other assets transferred to intangible assets during the period.

0

118

0

-

-

-

-

-

-

-

Value of equipment purchases financed by the seller.

0

326

0

-

-

-

-

-

-

-

Refers to accrual of contingent earn out payment during the period.

-

-

148

0

0

-

-

-

-

-

Issuance of common stock for net assets of business acquired

443

0

1,682

0

0

-

-

-

-

-

Refers to contingent liability earn out payment during the period.

1,225

0

-

-

-

-

-

-

-

-